Analytical Data
-
Gene name
LRRC34
- Application
-
Alternative Names
LRRC34; Leucine-rich repeat-containing protein 34
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8IZ02
-
Expression Region
1-419aa
-
AA Sequence
MGSSREAARAPARSPAWASTQASTPGAALAVQRESPESGLQKHYSNLCMEKSQKINPFILHILQEVDEEIKKGLAAGITLNIAGNNRLVPVERVTGEDFWILSKILKNCLYINGLDVGYNLLCDVGAYYAAKLLQKQLNLIYLNLMFNDIGPEGGELIAKVLHKNRTLKYLRMTGNKIENKGGMFFAAMLQINSSLEKLDLGDCDLEESTVHVGRMLKENHCLVALHMCKHDIKNSGIQQLCDALYLNSSLRYLDVSCNKITHDGMVYLADVLKSNTTLEVIDLSFNRIENAGANYLSETLTSHNRSLKALSVVSNNIEGEGLVALSQSMKTNLTFSHIYIWGNKFDEATCITYSDLIQMGCLKPDNTDVEPFVVDGRVYLAEVSNGLKKHYYWTSTYGESYDHSSNAGFALVPVGQQP
-
Molecular Weight
72.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LRRC34 (Leucine-Rich Repeat Containing 34) is a protein that has garnered attention in recent years due to its potential roles in cellular processes and its implications in various diseases, especially cancers. As a member of the leucine-rich repeat (LRR) protein family, LRRC34 is believed to be involved in protein-protein interactions and signaling pathways that are crucial for cell growth, differentiation, and apoptosis. Initial studies suggest that alterations in LRRC34 expression may influence tumor progression and metastasis, making it a candidate for further investigation as both a biomarker and a therapeutic target. Despite its promising implications, the precise molecular mechanisms and biological functions of LRRC34 remain poorly understood, warranting in-depth research. Understanding the structure, regulation, and interactions of LRRC34 could provide valuable insights into its role in normal physiology and its dysregulation in pathological conditions. Consequently, the development of recombinant LRRC34 protein has become essential for elucidating these aspects, facilitating studies on its functional roles and potential clinical applications. This research could ultimately contribute to better therapeutic strategies for cancers and other diseases associated with LRRC34 dysregulation.
